- Home
- SPRC vs QLGN Comparison
SPRC vs QLGN Comparison
Compare SPRC & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRC
- QLGN
- Stock Information
- Founded
- SPRC 2004
- QLGN 1996
- Country
- SPRC Israel
- QLGN United States
- Employees
- SPRC N/A
- QLGN N/A
- Industry
- SPRC Biotechnology: Pharmaceutical Preparations
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- SPRC Health Care
- QLGN Health Care
- Exchange
- SPRC Nasdaq
- QLGN Nasdaq
- Market Cap
- SPRC 3.4M
- QLGN 2.8M
- IPO Year
- SPRC N/A
- QLGN N/A
- Fundamental
- Price
- SPRC $0.31
- QLGN $3.75
- Analyst Decision
- SPRC
- QLGN
- Analyst Count
- SPRC 0
- QLGN 0
- Target Price
- SPRC N/A
- QLGN N/A
- AVG Volume (30 Days)
- SPRC 302.0K
- QLGN 10.5K
- Earning Date
- SPRC 02-15-2025
- QLGN 07-01-2025
- Dividend Yield
- SPRC N/A
- QLGN N/A
- EPS Growth
- SPRC N/A
- QLGN N/A
- EPS
- SPRC N/A
- QLGN N/A
- Revenue
- SPRC $1,306,000.00
- QLGN N/A
- Revenue This Year
- SPRC N/A
- QLGN N/A
- Revenue Next Year
- SPRC N/A
- QLGN N/A
- P/E Ratio
- SPRC N/A
- QLGN N/A
- Revenue Growth
- SPRC N/A
- QLGN N/A
- 52 Week Low
- SPRC $0.20
- QLGN $2.85
- 52 Week High
- SPRC $1.79
- QLGN $29.44
- Technical
- Relative Strength Index (RSI)
- SPRC 50.15
- QLGN 51.20
- Support Level
- SPRC $0.30
- QLGN $3.65
- Resistance Level
- SPRC $0.33
- QLGN $3.98
- Average True Range (ATR)
- SPRC 0.02
- QLGN 0.14
- MACD
- SPRC -0.00
- QLGN -0.01
- Stochastic Oscillator
- SPRC 58.82
- QLGN 51.32
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.